Asthma Trial, Recruiting NCT06377345 Sponsor: SingHealth Polyclinics Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06377345
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with asthma
  • Children aged 7 to 17, or adults aged 18 and older
  • People who are having an asthma flare-up on the day of their visit to the trial site
  • People who are willing to use a device called AeviceMD
  • People who have a smartphone that can download an app that connects to the AeviceMD device
  • People who have access to a WiFi connection to use with the AeviceMD device
  • People who speak English

Who may not be able to join:

  • People who are not able to give their own consent to participate
  • People who also have a lung condition called chronic obstructive pulmonary disease (COPD)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mabel QH Leow, PhD, SingHealth Polyclinics

Phone: +65 63507598

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
SingHealth Polyclinics
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
30 September 2025

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Rescue therapy; Dose of oral Prednisolone use; Visit to hospital emergency department; Hospitalisation; Euro Quality of Life 5 dimensions (EQ5D); Asthma quality of life questionnaire (AQLQ); Pediatric asthma quality of life questionnaire (PAQLQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov